NICE backs new treatment for chronic liver disease
admin 3rd March 2017 Uncategorised 0Intercept’s Ocaliva is being backed by the National Institute for Health and Care Excellence for routine NHS commissioning as a treatment for people with the chronic liver disease primary biliary cholangitis (PBC).
Source: News